FARAPULSE pulsed field ablation for heart rhythm problems
Part of Heart & circulation clinical trials.
This trial tests a new type of energy (pulsed field) to treat abnormal heart rhythms. It may be less damaging to nearby tissues than traditional ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a cardiac ablation procedure with the FARAPULSE system
- You are 18 years or older
- You are willing to follow the study schedule and give consent
- You do not have a heart infection, blood clot, or recent stroke or heart attack
- You are not pregnant or planning pregnancy
- You do not have a mechanical heart valve or certain heart repairs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.